Results 311 to 320 of about 1,261,156 (366)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system. [PDF]

Front Pharmacol
Wang S, Wang X, Ding J, Zhang X, Zhu H, Fan Y, Sun C.   +6 more
europepmc   +1 more source

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system. [PDF]

Front Pharmacol
Lu Y, Xu Q, Zhu S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)

Expert Opinion on Drug Safety, 2023
Introduction Recently, the European Medicines Agency (EMA) received reports of suicidal thoughts and self-injury associated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) liraglutide and semaglutide.
Roger S. McIntyre, R. Mansur, J. Rosenblat, A. Kwan   +3 more
semanticscholar   +1 more source

A real-world data analysis of acetylsalicylic acid in FDA Adverse Event Reporting System (FAERS) database

Expert Opinion on Drug Metabolism & Toxicology, 2023
Background Acetylsalicylic acid (Aspirin), one of the oldest medicines, is widely used in various clinical fields. However, numerous adverse events (AEs) have been reported.
Bin Zhao, Xiaohong Zhang, Moliang Chen, Y. Wang   +3 more
semanticscholar   +1 more source

Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel

American Journal of Hematology, 2021
AbstractThe U.S. Food and Drug Administration (FDA) approved the first chimeric antigen receptor T‐cell therapy, tisagenlecleucel, in August 2017. We sought to describe adverse events (AEs) reported to the FDA Adverse Event Reporting System (FAERS) for tisagenlecleucel in the post‐marketing period. We searched FAERS reports to identify U.S.
Graça M. Dores, Christopher Jason, Manette T. Niu, Silvia Perez‐Vilar   +3 more
openaire   +2 more sources

Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis

Expert Review of Vaccines, 2022
Background A few cases of Herpes Zoster and Simplex reactivation following COVID-19 immunization have been recently described, but the real extent of this suspected adverse event has not been elucidated yet.
M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, Chiara Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale   +9 more
semanticscholar   +1 more source

Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)

Vaccine, 2012
Adverse events following immunization (AEFI) reported to the national Vaccine Adverse Event Reporting System (VAERS) represent true causally related events, as well as events that are temporally, but not necessarily causally related to vaccine.We sought to determine if the causal relationships between the vaccine and the AEFI reported to VAERS could be
Nicola P. Klein, Elizabeth D. Barnett, Steve Black, Katherine M. Edwards, William G. Adams, Jerold Klein, Cornelia L. Dekker, Colin D. Marchant, Christine G. Casey, Roger Baxter, Philip LaRussa, Kathleen Jakob, Anita M. Loughlin, Robert Sparks   +13 more
openaire   +3 more sources

Introduction of a Mobile Adverse Event Reporting System Is Associated With Participation in Adverse Event Reporting

American Journal of Medical Quality, 2018
Physicians underutilize adverse event reporting systems. Web-based platforms have increased participation; thus, it was hypothesized that a mobile application would increase adverse event reporting. The authors developed a mobile reporting application for iOS and Android operating systems and performed a retrospective review on reporting rates by ...
Chuanhong Liao, Colin Pesyna, Daniel S. Rubin, Sharon Jakubczyk, Avery Tung   +4 more
openaire   +2 more sources

The vaccine adverse event reporting system (VAERS)

Vaccine, 1994
Immunizations against most vaccine-preventable diseases will be needed indefinitely unless the disease is eradicated. Public acceptance of immunizations may be threatened as vaccine coverage increases and disease decreases, however, due to the increase in both causally and coincidentally related vaccine adverse events.
Suresh C. Rastogi, Scott W. Hayes, Jerome A. Donlon, Stephen L. Cochi, Steven G. F. Wassilak, John R. Mullen, Robert T. Chen   +6 more
openaire   +3 more sources

Antidepressants-related cardiovascular adverse events using the adverse event reporting system

Psychiatry Research, 2018
The aim of this study was to evaluate clinical manifestations and the age and sex distribution of cardiovascular adverse events (CVAEs) related to antidepressants. The FDA Adverse Event Reporting System (FAERS) and Korea Adverse Event Reporting System (KAERS) database records on patients prescribed antidepressants were used.
Jae Hyun Kim, Young Won Kim, Yun-Kyoung Song, Yoon Kyong Lee, In-Wha Kim, Jung Su Shin, Jung Mi Oh   +6 more
openaire   +2 more sources